| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.53 | 1e-28 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.39 | 2e-28 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.38 | 7e-26 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.37 | 4e-24 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.32 | 3e-21 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.33 | 5e-21 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.31 | 5e-20 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.34 | 9e-19 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-17 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-16 |